Metropolitan Life Insurance Company (MetLife)’s TransDigm Group TDG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-2,243
Closed -$2.76M – 1894
2024
Q1
$2.76M Sell
2,243
-10
-0.4% -$11.3K 0.12% 151
2023
Q4
$2.28M Sell
2,253
-31
-1% -$28.6K 0.11% 166
2023
Q3
$1.93M Buy
2,284
+9
+0.4% +$7.9K 0.1% 168
2023
Q2
$2.03M Sell
2,275
-46
-2% -$36.4K 0.1% 172
2023
Q1
$1.71M Sell
2,321
-612
-21% -$437K 0.09% 206
2022
Q4
$1.85M Sell
2,933
-87
-3% -$51.3K 0.08% 237
2022
Q3
$1.58M Sell
3,020
-56
-2% -$33.4K 0.08% 259
2022
Q2
$1.65M Sell
3,076
-127
-4% -$75K 0.07% 257
2022
Q1
$2.09M Sell
3,203
-3,416
-52% -$2.19M 0.07% 247
2021
Q4
$4.21M Sell
6,619
-162
-2% -$101K 0.06% 270
2021
Q3
$4.24M Sell
6,781
-7,763
-53% -$4.85M 0.06% 249
2021
Q2
$9.41M Buy
14,544
+7,290
+100% +$4.57M 0.07% 224
2021
Q1
$4.26M Sell
7,254
-333
-4% -$196K 0.06% 251
2020
Q4
$4.7M Sell
7,587
-274
-3% -$151K 0.07% 213
2020
Q3
$3.73M Buy
7,861
+120
+2% +$56.4K 0.06% 243
2020
Q2
$3.42M Sell
7,741
-1,604
-17% -$607K 0.06% 260
2020
Q1
$2.99M Buy
9,345
+15
+0.2% +$8.17K 0.06% 267
2019
Q4
$5.22M Sell
9,330
-19
-0.2% -$10.4K 0.08% 206
2019
Q3
$4.87M Sell
9,349
-292
-3% -$150K 0.08% 214
2019
Q2
$4.66M Buy
9,641
+522
+6% +$244K 0.08% 224
2019
Q1
$4.14M Sell
9,119
-336
-4% -$136K 0.08% 220
2018
Q4
$3.22M Sell
9,455
-32
-0.3% -$11K 0.06% 246
2018
Q3
$3.53M Sell
9,487
-261
-3% -$94K 0.06% 265
2018
Q2
$3.36M Buy
9,748
+109
+1% +$35.8K 0.05% 288
2018
Q1
$2.96M Buy
9,639
+70
+0.7% +$20.6K 0.04% 330
2017
Q4
$2.63M Sell
9,569
-15,407
-62% -$4.19M 0.03% 383
2017
Q3
$6.38M Sell
24,976
-600
-2% -$162K 0.04% 437
2017
Q2
$6.88M Sell
25,576
-909
-3% -$231K 0.05% 385
2017
Q1
$5.83M Sell
26,485
-586
-2% -$140K 0.04% 488
2016
Q4
$6.74M Sell
27,071
-721
-3% -$189K 0.05% 397
2016
Q3
$8.04M Sell
27,792
-1,761
-6% -$494K 0.06% 307
2016
Q2
$7.79M Buy
29,553
+25,559
+640% +$6.24M 0.06% 314
2016
Q1
$880K Hold
3,994
– – 0.01% 1237
2015
Q4
$912K Buy
3,994
+107
+3% +$24.1K 0.01% 1234
2015
Q3
$826K Hold
3,887
– – 0.01% 1293
2015
Q2
$873K Buy
3,887
+157
+4% +$35.2K 0.01% 1381
2015
Q1
$816K Hold
3,730
– – 0.01% 1319
2014
Q4
$732K Buy
3,730
+99
+3% +$18.7K 0.01% 1522
2014
Q3
$669K Sell
3,631
-27
-0.7% -$4.82K ﹤0.01% 1526
2014
Q2
$612K Buy
3,658
+53
+1% +$9.55K ﹤0.01% 1689
2014
Q1
$668K Hold
3,605
– – ﹤0.01% 1607
2013
Q4
$580K Hold
3,605
– – ﹤0.01% 1710
2013
Q3
$500K Sell
3,605
-48
-1% -$6.83K ﹤0.01% 1747
2013
Q2
$573K Buy
+3,653
New +$548K ﹤0.01% 1609

Other funds holding TDG

Metropolitan Life Insurance Company (MetLife)'s TDG Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of TransDigm Group (TDG) in Q2 2024, closing a stake of 2,243 shares — an estimated $2.76M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TDG in Q2 2013 and held it in 44 quarters. The position peaked at $9.41M in Q2 2021. 1,002 funds tracked by Wall St. Rank hold TDG as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining TransDigm Group position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,243 TransDigm Group shares in Q2 2024, an estimated $2.76M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in TransDigm Group in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s TransDigm Group position peaked at $9.41M in Q2 2021.
  • 1,002 funds tracked by Wall St. Rank held TransDigm Group as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.